Venritidine
Alternative Names: D 16637Latest Information Update: 28 Nov 1997
At a glance
- Originator Unknown
- Developer Helopharm
- Class Antihistamines
- Mechanism of Action Histamine H2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 28 Nov 1997 No-Development-Reported for Gastric ulcer in Germany (Unknown route)
- 28 Nov 1997 No-Development-Reported for Gastric ulcer in United Kingdom (Unknown route)